Interestingly, we detected no different STAT5 signaling activities in leukemia samples of both TTL phenotypes suggesting that TTLshort/high mTOR activity ALL is not associated with these gene alterations and corresponding upstream kinase activations. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.